The global interventional neurology market size is estimated to grow USD 3722.52 million by 2027 from USD 2434.98 million in 2022, growing at a CAGR of 8.86% during the forecast period.
Interventional neurology is a non-surgical specialty that uses image-guided techniques, minimally invasive, to treat many complicated and dangerous diseases of the brain, neck, and spine. The specialty for the treatment of these neurovascular diseases is known as neurosurgery. Various materials such as cobalt, nitinol, and platinum are used in neurovascular devices to achieve specific ischemic stroke prevention and aneurysm repair.
Y-O-Y growth in the patient population, advancements in technology, and favorable reimbursements across mature markets, increasing healthcare infrastructure across the developing countries are majorly accelerating the global interventional neurology market.
Growing target patient populations, ongoing product development and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across developing markets, and growing consumer demand for successful neurovascular devices are major factors driving interventional neurology market growth. One of the key drivers of the industry is the rising number of cases of neurological diseases. For example, Alzheimer's disease is responsible for almost a quarter of the 1.2 million brain disorders. Another driving factor is the advice of numerous reputable organizations for stroke care. In the coming years, this could lead to increased demand for these devices.
Furthermore, an increasing number of companies in the field of neurovascular therapies and increased awareness among neurosurgeons regarding minimally invasive surgical procedures are propelling the market's growth rate. Strong focus on research & development leading to new product launches and product enhancements are ascribed to bolster the market's demand. In addition, lower product costs due to the strengthening of distribution networks and localized manufacturing, the rapid rise in the geriatric population, and high-stress levels in young people fuel the demand of the interventional neurology market.
The ongoing healthcare reforms in the United States, lack of skilled neurosurgeons, and stringent regulatory bodies across significant markets hinder the growth of the Interventional neurology market.
The growth for the global interventional neurology market is further expected to be hindered by a lack of qualified interventional neurologists and strict regulatory procedures. Also, strict requirements for approving new technologies are impeding the demand of the interventional neurologist market. Furthermore, the market is expected to be restrained during the forecast period due to high procedure costs, a lack of disposable income in undeveloped regions, and a lack of well-established reimbursement policies.
Growing demand for minimally invasive neurosurgical procedures and developing research activities in neurovascular therapies are expected to generate substantial growth opportunities in the Interventional neurology market over the forecast period. According to the Indian Brand Equity Foundation, the government spent USD 1.14 billion in 2018 to treat and raise awareness of CNS disorders due to increased cases. Besides, overall government spending on mental health care accounts for 2.4% of total government health spending in the United States. The government's median allocation of funds in psychiatric hospitals accounts for 80% of total government health spending.
The Food and Drug Administration (FDA) strictly regulates medical device approval based on their classification. There is very little class I neurological equipment. Most neurological devices are categorized as Class II or Class III, with ventricular needles and anvils used to shape skull plates being examples of Class I devices. Neurostimulators, aneurysm films, and blood clot retrievers are examples of Class II products. Deep brain stimulators and medical instruments for the treatment of brain tumors are examples of Class III devices. Class III medical device approval is difficult and requires clinical trials. The trials' duration will vary from 36 months to more than a year, depending on the nature of the clinical trials and any additional details required by the FDA. Companies engaged in the manufacture of neurological products are the major challenges faced by the delay in regulatory approvals and the high cost of interventional devices.
Impact of Covid-19 on Interventional Neurology Market:
The global interventional neurology market is a competitive industry with many growth opportunities. Still, this market shows the decline is largely due to global resource supply and demand mismatches caused by the COVID-19 outbreak. Interventional neurology is a subspecialty of neurology that uses minimally invasive image-guided techniques to treat major diseases of the brain, spine, and neck. However, due to governments' restrictions in various countries to contain the virus's spread, there is an insufficient supply of equipment used in neurological disease treatment. As a result, the market has seen slow growth during the pandemic period. However, the market is expected to have significant growth opportunities in 2021.
Market Size Available
2021 to 2027
2022 to 2027
By Technology, Product, End-User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
This market research report on the global interventional neurology market has been segmented and sub-segmented based on technology, product, end-user, and region.
Interventional Neurology Market - By Technology:
Based on the technology, the embolization and coiling segment is anticipated to have the largest share of 72.17% in the global interventional neurology market during the forecast period. This segment is expected to dominate the market as a result of a growing number of interventional procedures. Next in line, the balloon angioplasty segment is considered to produce profitable outcomes over the analysis period globally due to the high occurrence rate of diseases like cerebral stroke.
Interventional Neurology Market - By Product:
Based on the product, the carotid stents are projected to hold the largest share in the global interventional neurology market globally as of increasing occurrence rate of chronic nervous disorders, and increasing R&D investments and growing medical expenses are expected to lead the segment growth in this market.
Interventional Neurology Market - By End User:
Based on the end-user, the hospital segment is expected to lead the interventional neurology market throughout the period due to the growing number of in-patient populations, well-organized healthcare infrastructure, well-established equipment, and skilled and experienced staff.
Interventional Neurology Market – By Region:
Regionally, The interventional neurology market in North America dominates the market and is estimated to continue the same trend during the forecast period. Due to well-organized healthcare infrastructure, growing consciousness in people, and full concentration on research and development. As a result, the U.S is anticipated to lead the North American market.
The interventional neurology market in Europe is projected to stand as the second-largest share throughout the period due to the increasing aging population, advanced technologies and growing investments and funds from government and other organizations, and favorable reimbursement policies.
The interventional neurology market in Asia-Pacific is considered to have the quickest growth during the historic period due to increasing expenditure on the healthcare domain, growing perforation of the key players in this region.
The interventional neurology market in Latin America is likely to project stable and steady growth over the analysis period, growing demand for neurovascular devices, developing healthcare infrastructure.
The interventional neurology market in Middle East & Africa is predicted to occupy the least share in the global interventional neurology market from 2020 to 2025. On the contrary, Africa is leading the market. The growth is attributed to increasing health problems related to diseases, rising stress of neurological disorders, which has been growing over the past years globally during the forecasting framework.
KEY MARKET PARTICIPANTS:
Companies leading the global interventional neurology market profiled in the report are Stryker Corporation, Medtronic plc, Johnson & Johnson, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Microport Scientific Corporation, and Medikit Co., Ltd.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Embolization and Coiling
5.1.4 Carotid Stenting
5.1.6 Micro support devices
5.1.8 Y-o-Y Growth Analysis, By Technology
5.1.9 Market Attractiveness Analysis, By Technology
5.1.10 Market Share Analysis, By Technology
5.2.2 Carotid Stent
5.2.4 Flow Diversion
5.2.6 Suction Device
5.2.7 stenting systems
5.2.8 Clot Retrieval
5.2.10 Y-o-Y Growth Analysis, By Product
5.2.11 Market Attractiveness Analysis, By Product
5.2.12 Market Share Analysis, By Product
5.3.3 Ambulatory centers
5.3.4 Neurology clinics
5.3.6 Y-o-Y Growth Analysis, By End-users
5.3.7 Market Attractiveness Analysis, By End-users
5.3.8 Market Share Analysis, By End-users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Technology
188.8.131.52 By Product
184.108.40.206 By End-users
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Technology
22.214.171.124 By Product
126.96.36.199 By End-users
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Technology
220.127.116.11 By Product
18.104.22.168 By End-users
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Stryker Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic plc
8.3 Johnson & Johnson
8.4 Terumo Corporation
8.5 Penumbra Inc.
8.6 Abbott Laboratories
8.7 Merit Medical Systems Inc.
8.8 W. L. Gore & Associates Inc.
8.9 Microport Scientific Corporation
8.10 Medikit Co., Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.